-
Mashup Score: 0Why the business side of cardiology was a key focus at ACC.24 - 1 hour(s) ago
Alison Bailey, MD, co-chair of the business of cardiology sessions at ACC.24, emphasized that reimbursement cuts can have a long-term negative impact on patient.
Source: cardiovascularbusiness.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 1CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine | CV Board - 18 hour(s) ago
WASHINGTON (April 25, 2024) – Efforts by the American College of Cardiology, the American Heart Association, the Heart Failure Society of America, the Heart Rhythm Society and The Society for Cardiovascular Angiography & Interventions to create a new, independent Board of Cardiovascular Medicine under the American Board of Medical Specialties (ABMS) are closer to becoming a reality with the creation of a formal Board of Directors and the announcement by the ABMS Advisory Board on Specialty Board Developmen
Source: cvboard.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 2Poor Sleep Quality Linked to CVD Events and Mortality - 23 hour(s) ago
Low delta entropy on EEG was able to better predict outcomes than traditional overnight polysomnography measures.
Source: www.tctmd.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 1Self-Selection for Statin Appears Safe, Effective - 2 day(s) ago
Nonprescription rosuvastatin pans out in a second trial
Source: www.medpagetoday.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 0
After ORBITA-COSMIC, Reducer device’s mechanism of benefit remains unknown
Source: www.medpagetoday.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 4
Randomized trial shows better outcomes for patients with acute coronary syndromes
Source: www.medpagetoday.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 4
Patient acceptance could be an advantage, researchers say
Source: www.medpagetoday.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 3IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease - 4 day(s) ago
IVUS-DCB is now the second trial to support intravascular imaging in peripheral interventions—what will it take to increase its use?
Source: www.tctmd.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 1Telemedicine Strategy After MI Scores a Win in TELE-ACS - 8 day(s) ago
Patients went home with self-testing devices plus remote access to a cardiologist—readmissions, events, and symptoms improved.
Source: www.tctmd.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 5
Contact: Nicole Napoli , nnapoli@acc.org, 202-669-1465 People who have had a heart attack or who are at risk for a heart attack and who stopped taking aspirin alongside the P2Y 12 inhibitor ticagrelor one month after undergoing percutaneous coronary intervention (PCI) saw a significantly reduced risk of clinically meaningful bleeding with no increased risk of clotting-related adverse events at 12 months compared with patients who continued taking aspirin and ticagrelor for a full year, in a study presented
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
📰 📽️ @CardioBusiness looks at how ACC doubled the number of business-related sessions at #ACC24 as economics and business finance literacy are more important than ever as reimbursements continue to decline. Hear from session co-chair @a_l_bailey: https://t.co/ZZjaYhTbpS